Publications by authors named "Rob de Haan"

Claim this Profile
D
Development and Validation of the Satisfaction Concerning Stoma Care Questionnaire (SSCQ).
Sebastiaan L van der Storm, Esther Z Barsom, Rob J de Haan, Marlies P Schijven

J Wound Ostomy Continence Nurs· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
Sander Rm Bus, Rob J de Haan, Marinus Vermeulen, Ivo N van Schaik, Filip Eftimov

Cochrane Database Syst Rev· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical results and quality of life after subtotal petrosectomy.
Simon Geerse, Rob J de Haan, Fenna A Ebbens, Maarten J F de Wolf, Erik van Spronsen

Eur Arch Otorhinolaryngol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP Study.
Henrieke L Frequin, Jason Schouten, Constant V M Verschuur, Sven R Suwijn, Judith A Boel, Rob J de Haan

Neurology· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrasound and MR muscle imaging in new onset idiopathic inflammatory myopathies at diagnosis and after treatment: a comparative pilot study.
Anne W Walter, Johan Lim, Joost Raaphorst, Frank F Smithuis, J Michiel den Harder, Rob J de Haan

Rheumatology (Oxford)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness and Cost-Utility of Early Levodopa in Parkinson's Disease.
Constant V M Verschuur, Sven R Suwijn, Rob J de Haan, Judith A Boel, Bart Post

J Parkinsons Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of disability in idiopathic inflammatory myopathy: a call for linearity.
Minoesch Min, Anne W Walter, Johan Lim, Filip Eftimov, Camiel Verhamme, Rob J de Haan

Rheumatology (Oxford)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Max E Adrichem, Ilse M Lucke, Alexander F J E Vrancken, H Stephan Goedee, Luuk Wieske, Rob J de Haan

Brain· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dutch injection versus surgery trial in patients with carpal tunnel syndrome (DISTRICTS): protocol of a randomised controlled trial comparing two treatment strategies.
Wijnand A C Palmbergen, Rob M A de Bie, Tim W H Alleman, Esther Verstraete, Korne Jellema, Rob de Haan

BMJ Open· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoglobulin for multifocal motor neuropathy.
Stephen Keddie, Filip Eftimov, Leonard H van den Berg, Ruth Brassington, Rob J de Haan

Cochrane Database Syst Rev· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow-up.
Tom J M van Mierlo, Elisabeth M J Foncke, Bart Post, Ben A Schmand, Bastiaan R Bloem, Rob J de Haan

Brain Behav· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study.
Johan Lim, Filip Eftimov, Camiel Verhamme, Esther Brusse, Jessica E Hoogendijk, Rob J De Haan

Rheumatology (Oxford)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Endovascular Treatment With Medical Management vs Standard Care on Severe Cerebral Venous Thrombosis: The TO-ACT Randomized Clinical Trial.
Jonathan M Coutinho, Susanna M Zuurbier, Marie-Germaine Bousser, Xunming Ji, Patricia Canhão, Rob J de Haan

JAMA Neurol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of cognitive and behavioural impairment in early amyotrophic lateral sclerosis.
Emma Beeldman, Rosanne Govaarts, Marianne de Visser, Michelle Klein Twennaar, Anneke J van der Kooi, Rob J de Haan

J Neurol Neurosurg Psychiatry· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favourable outcome without psychotherapy in patients with functional neurologic disorder.
Marinus Vermeulen, Rob J de Haan

J Clin Neurosci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension.
Yasmine Emma Maria Dreissen, Joke M Dijk, Jeannette M Gelauff, Evelien Zoons, Daniël van Poppelen, Rob J de Haan

J Neurol Neurosurg Psychiatry· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease.
Constant V M Verschuur, Sven R Suwijn, Judith A Boel, Bart Post, Bas R Bloem, Rob J de Haan

N Engl J Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cognitive profile of behavioural variant FTD and its similarities with ALS: a systematic review and meta-analysis.
Emma Beeldman, Joost Raaphorst, Michelle Klein Twennaar, Rosanne Govaarts, Yolande A L Pijnenburg, Rob J de Haan

J Neurol Neurosurg Psychiatry· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack.
Thomas P Zonneveld, Edo Richard, Mervyn DI Vergouwen, Paul J Nederkoorn, Rob de Haan

Cochrane Database Syst Rev· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinician and patient perceptions of free will in movement disorders: mind the gap.
Sandra Ma van der Salm, Daniëlle C Cath, Anne-Fleur van Rootselaar, Johannes Htm Koelman, Rob J de Haan

J Neurol Neurosurg Psychiatry· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with functional neurological symptoms: a single-centre randomised controlled trial.
Marc Pleizier, Rob J de Haan, Marinus Vermeulen

J Neurol Neurosurg Psychiatry· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical decision-making in functional and hyperkinetic movement disorders.
Sandra M A van der Salm, Anne-Fleur van Rootselaar, Daniëlle C Cath, Rob J de Haan, Johannes H T M Koelman

Neurology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Pulsed Electromagnetic Fields After Debridement and Microfracture of Osteochondral Talar Defects: Response.
Mikel L Reilingh, Christiaan J A van Bergen, Rogier M Gerards, Inge C van Eekeren, Rob J de Haan

Am J Sports Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe anemia in Malawian children.
Job Cj Calis, Kamija S Phiri, E Brian Faragher, Bernard J Brabin, Imelda Bates, Rob J de Haan

Malawi Med J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis